Here is a much more detailed, easy-to-understand explanation of every topic, sourced directly from Goldman-Cecil Medicine, Bailey & Love's Surgery, Barash Clinical Anesthesia, Henry's Laboratory Methods, and Scott-Brown's Surgery:
🩸 Blood Products & Blood Transfusion — Detailed Easy Guide (From Standard Textbooks)
PART 1: BLOOD PRODUCTS IN DETAIL
🔴 Whole Blood
Whole blood contains everything - red cells, white cells, platelets, and all plasma proteins including clotting factors. In civilian practice, it is rarely used because it is seen as an "inefficient" use of a limited resource - you are giving a patient things they may not need. However, in military medicine and trauma, whole blood has a big advantage: it is coagulation-factor rich, and if fresh, it is more metabolically active than stored blood. This is why trauma surgeons are now revisiting "walking blood banks" (soldiers donating fresh blood directly on the battlefield).
- Bailey & Love's Surgery 28th ed.
🔴 Packed Red Blood Cells (PRBC)
When a unit of whole blood is spun in a centrifuge, the heavy red cells fall to the bottom and the plasma floats on top. The plasma is removed, and what remains is a concentrated pack of red cells - this is PRBC.
- Volume per unit: approximately 330 mL
- Haematocrit: 50-70% (much thicker/more concentrated than normal blood which is ~45%)
- Effect: 1 unit raises Hb by 1 g/dL and haematocrit by 3%
- Stored in SAG-M (as additive) for up to 6 weeks at 2-6°C
PRBC is the go-to for anaemia. You are giving only what the patient needs (red cells for oxygen carrying), without the extra volume load of whole blood.
🟡 Platelets
Platelets are tiny cell fragments that form the first plug when a blood vessel is cut. Without enough platelets, you bleed from wounds and even spontaneously.
- Supplied as a pooled platelet concentrate (from 4-6 donors pooled together)
- Contains approximately 250 × 10⁹/litre platelets
- Stored on a special agitator (rocking machine) at 20-24°C - room temperature!
- Shelf life: only 5 days (shortest of all blood products)
- Effect: 1 unit raises platelets by 5,000-10,000 /µL
Why room temperature? If you refrigerate platelets, they get "activated" and clump together prematurely - they stop working. The gentle rocking prevents them from settling and keeps them functioning.
Platelets are given to patients who are thrombocytopenic (low platelet count) or who have platelet dysfunction (e.g., from aspirin/clopidogrel use) who are bleeding or going for surgery. Patients on clopidogrel who are actively bleeding during major surgery may need continuous platelet infusion throughout the operation - that's how severely clopidogrel blocks platelets.
- Bailey & Love's Surgery 28th ed.
🟢 Fresh Frozen Plasma (FFP)
FFP is the liquid part of blood (plasma) that has been separated from cells and immediately frozen at -40°C to -50°C. "Fresh frozen" means it was frozen quickly so all the clotting factors are preserved.
- Contains all coagulation factors (I, II, V, VII, VIII, IX, X, XI) and fibrinogen
- Shelf life: 2 years frozen
- Must be thawed before use - once thawed must be used within 20 minutes (the clotting factors degrade quickly)
- Volume: approximately 200-300 mL per unit
When to use FFP:
- Active haemorrhage with coagulopathy (clotting failure)
- Warfarin reversal - warfarin blocks factors II, VII, IX, X; FFP replenishes them
- Massive transfusion (as part of 1:1:1 ratio)
- Liver disease patients who can't make clotting factors
Important point on Rhesus: Rh-positive FFP CAN technically be given to an Rh-negative woman. But with large volumes, there may be tiny red cell fragments in the FFP, and this can cause Rh sensitisation in the woman - which is dangerous in future pregnancies. So anti-D immunoglobulin should be considered.
- Bailey & Love's Surgery 28th ed.
🔵 Cryoprecipitate
This is a supernatant precipitate - what remains when FFP is slowly thawed at 4°C and the white precipitate (which forms at the bottom) is collected and re-frozen.
Contents (memory: "8-13-F-vW"):
-
Factor VIII (antihemophilic factor)
-
Factor XIII (stabilises the clot)
-
Fibrinogen (the "glue" that holds the clot together)
-
von Willebrand Factor (vWF) (needed for platelet adhesion)
-
Stored at -30°C with a 2-year shelf life
-
Given in low-fibrinogen states (hypofibrinogenaemia), Factor VIII deficiency, Von Willebrand disease, and Haemophilia A (if concentrate not available)
Why is fibrinogen so important? During massive haemorrhage, fibrinogen is the first clotting factor to become critically low. Without fibrinogen, clots cannot form at all. Cryoprecipitate is given empirically (without waiting for lab tests) when a patient is bleeding massively.
- Bailey & Love's Surgery 28th ed.
🟣 Prothrombin Complex Concentrate (PCC)
PCC is a highly purified, concentrated extract made from pooled human plasma. It contains the vitamin K-dependent clotting factors.
Contents:
- Factor II (prothrombin)
- Factor IX
- Factor X
- Factor VII (may or may not be included - "4-factor PCC" includes it)
Main use: Emergency reversal of warfarin (warfarin blocks all 4 of these factors).
Why PCC is better than FFP for warfarin reversal:
- PCC works in minutes; FFP takes longer
- PCC needs small volume (e.g., 50 mL); FFP needs large volume (litres) - huge difference in fluid load
- PCC carries lower infection risk (it's treated/purified)
- Bailey & Love's Surgery 28th ed.
🔶 Leukoreduction (Leukodepletion)
Your slide mentions this - what does it mean?
Leukoreduction = filtering out white blood cells (WBCs/leukocytes) from blood products before transfusion.
Why remove WBCs?
- Prevent febrile non-haemolytic reactions - the most common transfusion reaction is caused by recipient antibodies attacking donor WBCs, releasing fever-causing cytokines
- Prevent variant Creutzfeldt-Jakob disease (vCJD) transmission - prion proteins (the cause of "mad cow" disease in humans) may be carried by WBCs
- Reduce immunogenicity - donated WBCs can prime the recipient's immune system, creating antibodies that cause problems in future transfusions
In the UK, universal leukodepletion has been standard practice for all blood components since 1999. As a result, the incidence of FNHTR has dropped dramatically - from as high as 30% down to 0.01-1%.
- Barash Clinical Anesthesia 9th ed. and Goldman-Cecil Medicine
PART 2: BLOOD STORAGE - THE CHEMISTRY IN DETAIL
Why does blood need special storage solutions?
Fresh blood would clot within minutes in a bag - calcium is needed for clotting, and glucose is needed to keep cells alive. Storage solutions solve all these problems.
Breaking Down Each Ingredient
| Ingredient | Role | How It Helps |
|---|
| Citrate | Anticoagulant | Chelates (binds and removes) calcium ions - without Ca²⁺, the coagulation cascade stops completely. This is why blood does NOT clot in the bag. |
| Phosphate | Buffer | Prevents the pH from falling (blood gets acidic during storage due to cell metabolism). Also increases 2,3-BPG levels in RBCs, which lowers haemoglobin's affinity for oxygen, so O₂ is released more readily to tissues. |
| Dextrose (glucose) | Energy source | Red cells have no mitochondria - they make ATP only by glycolysis (using glucose). ATP is needed to run the sodium-potassium pump that keeps red cells the right shape and stops them from bursting. |
| Adenine | ATP synthesis | Helps the red cell regenerate ATP from AMP. Without adenine, ATP runs out and cells die rapidly. This is why CPDA lasts 5 weeks vs CPD's 2-3 weeks. |
| Saline | Dilutes the pack | Reduces viscosity so blood can actually flow through giving sets. |
| Mannitol | Osmotic agent | Prevents haemolysis (cells bursting). Acts as an osmotic membrane stabiliser. |
SAG-M Note
SAG-M cannot be used alone as a blood storage solution because it does not have citrate (the anticoagulant). It is used as an additive solution - added after the plasma has been removed from CPD-anticoagulated blood. The combination gives the best shelf life of 6 weeks.
PART 3: TRANSFUSION TRIGGERS IN DETAIL
Why did the "Hb 10 g/dL" rule get abandoned?
Historically, doctors transfused everyone to get their Hb above 10 g/dL. Large randomised trials (particularly the TRICC trial) showed this was wrong and harmful:
- More transfusions = more immune reactions, more infections, more organ failure
- Patients who were transfused "liberally" had higher morbidity and mortality
Current Restrictive Strategy (from Bailey & Love's Surgery)
| Patient Type | Transfuse When Hb < |
|---|
| Stable, not bleeding, not going for surgery | 6 g/dL |
| Actively bleeding, symptomatic, pre-operative | 8 g/dL |
| Cardiac ischaemia patients | 8-10 g/dL (higher threshold because the heart is very sensitive to low oxygen) |
| Septic shock | 7 g/dL (same outcome as 9 g/dL threshold - Goldman-Cecil Medicine) |
The rationale: a haemoglobin of 6 g/dL is perfectly acceptable in a resting patient with no active bleeding - the body compensates by increasing cardiac output and extracting more oxygen from what is available.
PART 4: MASSIVE BLOOD TRANSFUSION - IN DETAIL
What is it?
Any ONE of the following (Henry's Laboratory Methods):
- Replacement of one entire blood volume within 24 hours (blood volume = ~5L in a 70 kg adult = 8% of body weight)
- Transfusion of >10 units PRBC in 24 hours
- Transfusion of ≥3 units PRBC in 1 hour when ongoing need is expected
- Blood loss of >150 mL/minute (severe ongoing haemorrhage)
Why Does Coagulopathy Develop in Massive Transfusion?
This is the most important complication - you can understand it step by step:
Step 1: Patient is bleeding massively. You transfuse large volumes of PRBC (red cells only) and crystalloid (saline).
Step 2: The PRBC contains NO platelets and NO clotting factors. The crystalloid further dilutes what's there.
Step 3: The patient's own platelets and clotting factors are now so diluted (haemodilution) that they cannot form effective clots.
Step 4: The patient bleeds even more - a vicious cycle. This is called dilutional coagulopathy.
Additionally:
- Hypothermia (from cold stored blood) makes clotting enzymes work poorly
- Acidosis (from poor perfusion) further impairs clotting
- Calcium depletion - remember, stored blood has citrate which binds calcium. When you give large amounts of stored blood, the citrate binds the patient's own calcium - hypocalcaemia develops, worsening coagulopathy
- DIC (Disseminated Intravascular Coagulation) can develop from the underlying injury
Together these are called the "Lethal Triad" of massive trauma: Hypothermia + Acidosis + Coagulopathy.
The 1:1:1 Balanced Transfusion Strategy
The solution: give all three components together from the start, in equal proportions:
RBC : FFP : Platelets = 1 : 1 : 1
This mimics whole blood. Multiple military and civilian studies show this reduces mortality compared to giving just red cells. - Henry's Laboratory Methods, Goldman-Cecil Medicine
Complications of Massive Transfusion
| Complication | Mechanism | Key Feature |
|---|
| Hypocalcaemia | Citrate in stored blood binds patient's Ca²⁺ | Tingling, tetany, cardiac arrhythmia → give IV Calcium gluconate |
| Hyperkalaemia | RBCs leak K⁺ into storage solution over time (stored blood is high in K⁺) | Risk of cardiac arrhythmia |
| Hypothermia | Cold stored blood (2-6°C) enters patient rapidly | Worsens coagulopathy, causes arrhythmia → use blood warmers |
| Coagulopathy | Dilution of clotting factors + platelets | Bleeding from all sites → 1:1:1 ratio + cryoprecipitate |
| Metabolic acidosis | Citric acid metabolism + poor tissue perfusion | Initially acidosis, may convert to metabolic alkalosis once citrate is metabolised |
| Iron overload | Each PRBC unit contains ~250 mg elemental iron | Mainly in patients needing repeated transfusions (e.g., thalassaemia) |
PART 5: HAEMORRHAGIC SHOCK CLASSIFICATION (Bonus from Goldman-Cecil)
| Class | Blood Loss (mL) | % Volume | Pulse | BP | Urine Output | Mental Status |
|---|
| I | Up to 750 | Up to 15% | <100 | Normal | >30 mL/hr | Slightly anxious |
| II | 750-1500 | 15-30% | >100 | Normal | 20-30 mL/hr | Mildly anxious |
| III | 1500-2000 | 30-40% | >120 | Decreased | 5-15 mL/hr | Anxious, confused |
| IV | >2000 | >40% | >140 | Decreased | Negligible | Confused, lethargic |
Class I and II: crystalloid. Class III and IV: crystalloid + blood.
PART 6: TRANSFUSION REACTIONS - DETAILED EXPLANATIONS
🔴 Acute Haemolytic Transfusion Reaction (AHTR)
Frequency: ~1 in 110,000 transfusions (rare but deadly)
What happens step by step:
- Wrong blood group is given (most commonly ABO mismatch - e.g., group A blood given to a group O patient)
- The recipient already has pre-formed antibodies (anti-A or anti-B IgM antibodies - everyone with blood group O has both)
- These antibodies immediately attach to the transfused red cells → form antigen-antibody complexes
- This activates the complement cascade → complement drills holes in the red cells → intravascular haemolysis (red cells burst inside blood vessels)
- Free haemoglobin floods the blood → damages kidneys → oliguria/acute kidney injury
- Clotting cascade is activated → DIC (blood clots everywhere and uses up all clotting factors)
- Inflammatory mediators cause hypotension → shock → multi-organ failure
Symptoms:
- Burning pain along the vein (very first symptom - the patient feels something is wrong immediately)
- Fever, chills
- Back/flank pain (kidneys)
- Hypotension
- Oliguria (most important sign - a sign of kidney damage from haemoglobin)
- Dark/red urine (haemoglobinuria)
In an anaesthetised patient: They can't tell you about burning pain. The only clues are:
- Unexplained hypotension
- Bleeding from the wound site (DIC consuming all clotting factors)
Management:
- Stop transfusion immediately
- Keep the IV line open with normal saline
- Send samples to blood bank to recheck compatibility
- IV fluids to maintain urine output
- Diuretics (furosemide/mannitol) to force urine flow and flush the kidneys
- Treat DIC and hypotension if present
- Goldman-Cecil Medicine, Barash Anesthesia
🟡 Febrile Non-Haemolytic Transfusion Reaction (FNHTR)
Frequency: ~1 in 1,100 transfusions - the most common reaction
Definition: Temperature rise of ≥1°C (or >38°C) with or without chills, occurring within 4 hours of transfusion, with NO haemolysis.
Mechanism:
There are two ways this happens:
- Recipient's antibodies (from previous transfusions or pregnancies) attack donor WBCs (HLA antigens)
- During platelet storage, donor WBCs break down and release cytokines (inflammatory signals). These pre-formed cytokines trigger fever when transfused
Symptoms: Fever, chills, rigors, nausea, headache - but NO haemolysis, NO hypotension
Important: You must first rule out haemolytic reaction (which also causes fever) before diagnosing FNHTR.
Treatment: Stop transfusion. Give paracetamol/antipyretics. Usually self-limiting.
Prevention: Leukoreduction (removing WBCs). The incidence dropped from 30% to <1% after universal leukodepletion.
- Goldman-Cecil Medicine, Scott-Brown's Surgery, Barash Clinical Anesthesia
🟠 Allergic Transfusion Reactions
Frequency: ~1 in 1,200 transfusions
Mechanism: The recipient's immune system reacts to plasma proteins in the donor product (not red cells). This is an IgE-mediated or IgE-like immune response.
Range of severity:
- Mild: Urticaria (hives), itching, flushing - treat with antihistamines, can sometimes continue transfusion at slower rate
- Moderate: Angioedema, wheezing
- Severe (Anaphylaxis): Bronchospasm, hypotension, cardiovascular collapse - stop transfusion, give Adrenaline 1:1,000 IM
Special case - IgA deficiency: Some patients lack IgA and have developed anti-IgA antibodies. When they receive blood containing IgA (from donor plasma), they get anaphylaxis. These patients must receive IgA-deficient donor blood or washed blood products.
Premedication: Antihistamines before transfusion are commonly given to patients with a history of allergic reactions, though studies show mixed results.
- Goldman-Cecil Medicine, Barash Anesthesia
🔵 TRALI (Transfusion-Related Acute Lung Injury)
Frequency: ~1 in 140,000 - rare, but was the leading cause of transfusion-related death before recent prevention measures
Most commonly after: Platelets, FFP (plasma-containing products)
Mechanism - "Two-hit model":
- Hit 1: Patient has an underlying condition (surgery, trauma, infection) that has already "primed" the lungs - neutrophils are sitting in the pulmonary capillaries, slightly activated
- Hit 2: Donor blood contains anti-HLA antibodies (antibodies against white blood cells). These are especially common in blood from multiparous women (women who have had multiple pregnancies develop antibodies against their baby's HLA antigens). When transfused, these antibodies attack the primed neutrophils in the patient's lungs → massive inflammation → capillary leak → fluid floods the air spaces (non-cardiogenic pulmonary oedema)
Symptoms (within 6 hours of transfusion):
- Sudden severe hypoxia (low oxygen saturation)
- Hypotension (not hypertension like TACO)
- Bilateral infiltrates on chest X-ray (snow-storm appearance)
- No evidence of heart failure
Diagnosis: Bilateral infiltrates + hypoxia within 6 hours of transfusion + NO evidence of cardiogenic oedema
Treatment:
- Stop transfusion immediately
- Supportive care only - high-flow oxygen, mechanical ventilation if needed
- NO diuretics (the oedema is from capillary leak, not fluid overload - diuretics won't help and may cause hypotension)
- Most patients recover within 2-4 days
- 5-10% mortality rate
Prevention: Blood services now use plasma predominantly from male donors or tested antibody-negative donors, which has dramatically reduced TRALI incidence.
- Goldman-Cecil Medicine, Scott-Brown's Surgery, Barash Anesthesia
🟢 TACO (Transfusion-Associated Circulatory Overload)
Frequency: ~1 in 9,000 - actually more common than TRALI
Who gets it: Elderly patients, heart failure, renal failure, patients getting large volumes rapidly
Mechanism: Simple fluid overload. The patient's heart and kidneys cannot handle the extra volume being infused → fluid backs up into the lungs → hydrostatic (cardiogenic) pulmonary oedema
Symptoms (within 2-6 hours, sometimes up to 12 hours):
- Dyspnoea (breathlessness)
- Hypertension (key distinguishing feature from TRALI)
- Tachycardia
- Raised JVP, peripheral oedema, orthopnoea (can't breathe lying flat)
- Raised BNP/NT-proBNP (heart stress marker - elevated because the heart is struggling)
Treatment:
- Stop transfusion or slow it down significantly
- Diuretics (furosemide) - reduces fluid overload
- Sit patient upright
- Supplemental oxygen
- Goldman-Cecil Medicine, Scott-Brown's Surgery, Miller's Anesthesia
PART 7: TACO vs TRALI - The Full Comparison Table
| Feature | TACO | TRALI |
|---|
| Mechanism | Too much fluid, weak heart/kidneys | Immune - donor antibodies attack patient's lung neutrophils |
| Oedema type | Hydrostatic (cardiogenic - heart failure) | Permeability (non-cardiogenic - capillary leak) |
| Blood pressure | Hypertensive | Hypotensive |
| Onset | 2-6 h (up to 12 h) | Within 6 h |
| BNP level | Elevated (>1000 pg/mL) | Normal or slightly elevated |
| CXR | Cardiomegaly + bilateral oedema + pleural effusions | Bilateral infiltrates, no cardiomegaly |
| Risk factors | Heart failure, elderly, renal insufficiency | Any patient; multiparous donor plasma; ICU patients |
| Treatment | Diuretics + O₂ | Supportive O₂/ventilation - NO diuretics |
| Prognosis | Good with treatment | 5-10% mortality |
| Brain natriuretic peptide | High - helps differentiate | Normal or low |
Key memory trick: TACO = Too much fluid = Hypertension = Diuretics fix it. TRALI = Immune attack on lungs = Hypotension = NO diuretics.
PART 8: AUTOLOGOUS TRANSFUSION - IN DETAIL
"Autologous" means you are your own blood donor.
Pre-Donation (Preoperative Autologous Donation - PAD)
- Patient donates their own blood before elective surgery
- This blood is stored and re-transfused during the operation
- Advantages: Zero risk of immune reaction, no infection risk, no alloimmunisation
- Disadvantages: Expensive, needs planning, patient must be fit enough to donate
Your professor's protocol:
- Up to 5 units can be pre-donated
- First donation: 40 days before surgery (to give the body time to recover)
- Last donation: 3 days before surgery (fresh enough to be useful)
- Interval between donations: 3-4 days (time to recover each unit donated)
Intraoperative Cell Salvage
During surgery, blood that spills into the operative field is:
- Suctioned up
- Anticoagulated
- Filtered to remove bone fragments, fat, surgical debris
- Washed with saline
- Centrifuged to concentrate the red cells
- Re-infused back into the patient
This is particularly useful in cardiac surgery, orthopaedic surgery, vascular surgery where blood loss can be very large.
Contraindicated when: cancer surgery (risk of spreading cancer cells), infected field, bowel contents are present.
- Bailey & Love's Surgery 28th ed.
PART 9: CROSS-MATCHING AND BLOOD GROUPS
Why do we cross-match?
The aim is to ensure the patient receives compatible blood - i.e., the donor's red cells won't be attacked by the patient's antibodies.
Step 1 - ABO and Rhesus Typing
Everyone is either A, B, AB, or O, and either Rhesus positive (+) or negative (-).
| Blood Group | Red Cell Antigen | Plasma Antibodies |
|---|
| A | A antigen | Anti-B |
| B | B antigen | Anti-A |
| AB | A and B antigens | None (universal recipient) |
| O | None | Anti-A AND Anti-B (universal donor) |
Group O negative = universal donor (no antigens to react with anyone's antibodies)
Group AB positive = universal recipient (has no antibodies to react against any donor cells)
Step 2 - Full Cross-Match
- The patient's serum is mixed with the donor's red cells in the lab
- If agglutination (clumping) occurs → incompatible - don't use
- Takes up to 45 minutes
Step 3 - In Emergencies
- Type-specific blood (only ABO/Rhesus matched): Available in 10-15 minutes
- Group O negative blood (uncrossmatched): Available immediately - for life-threatening emergencies. Give O- to females of child-bearing age (to prevent Rh sensitisation in future pregnancies) and O+ to males.
- Bailey & Love's Surgery 28th ed.
PART 10: COAGULOPATHY MANAGEMENT IN MASSIVE HAEMORRHAGE
When a patient is bleeding massively:
1. Balanced 1:1:1 Transfusion - as discussed above, given from the very start
2. Tranexamic Acid (TXA)
- Most bleeding patients have hyperfibrinolysis - their fibrinolysis system (the system that breaks down clots) goes into overdrive, dissolving every clot that tries to form
- Tranexamic acid is an antifibrinolytic - it blocks plasmin from dissolving clots
- Should be given as early as possible (within 3 hours of injury - after 3 hours it can paradoxically worsen outcomes)
- Bailey & Love's Surgery 28th ed.
3. Fibrinogen/Cryoprecipitate
- Fibrinogen is the first clotting factor to critically fall during haemorrhage
- Give cryoprecipitate empirically (don't wait for lab results when bleeding is severe)
4. Laboratory Monitoring
- PT, APTT, fibrinogen levels
- Thromboelastometry (TEG/ROTEM) - a point-of-care test that gives a real-time picture of the entire clotting process in minutes. Much faster than sending blood to the lab. Guides targeted treatment.
- Platelet count - give concentrate if <50,000
PART 11: BLOOD SUBSTITUTES - IN DETAIL
Why do we even need substitutes? Because:
- Real blood is limited in supply
- Blood carries infection risk
- Blood has a short shelf life
- Blood needs complex storage and matching
Biomimetic (Haemoglobin-Based)
These copy what haemoglobin does - carry oxygen.
- Made from human or bovine (cow) haemoglobin, chemically modified to work outside red cells
- Problems: free haemoglobin outside red cells is toxic (causes vasoconstriction, kidney damage) - this is why these products have not yet passed large clinical trials
Abiotic (Perfluorocarbon-Based)
These are completely synthetic - not derived from blood at all.
- Perfluorocarbons are liquids that dissolve huge amounts of oxygen
- Must be breathed with high-concentration oxygen for them to work
- Problems: short half-life, need high FiO₂, some cardiovascular side effects
Both types are still largely experimental - not in routine clinical use. But they represent the future of "bloodless" resuscitation.
- Bailey & Love's Surgery 28th ed.
MASTER SUMMARY TABLE
| Topic | Key Facts |
|---|
| PRBC | Hct 50-70%, 330mL, raises Hb 1g/dL, stored 2-6°C, 6wk |
| Platelets | 250×10⁹/L, 20-24°C (agitator), 5 days, raises count 5-10k |
| FFP | All factors, -40°C, 2yr, give within 20min of thawing |
| Cryo | Factor VIII+XIII+Fibrinogen+vWF, -30°C, 2yr |
| PCC | Factor II+VII+IX+X, best for warfarin reversal |
| Transfusion trigger | Stable: <6 g/dL |
| Massive transfusion | >10 units/24h OR ≥3 units/1h with ongoing need |
| Balanced strategy | RBC:FFP:Platelets = 1:1:1 |
| Lethal triad | Hypothermia + Acidosis + Coagulopathy |
| MC reaction | FNHTR (1:1,100) |
| AHTR sign | Oliguria (awake) / Hypotension+bleeding (anaesthetised) |
| TRALI | Hypotensive, bilateral infiltrates, NO diuretics, 5-10% death |
| TACO | Hypertensive, raised BNP, respond to diuretics |
| Autologous | Up to 5 units; first donation 40 days before, last 3 days before |
| Tranexamic acid | Give early in massive haemorrhage - blocks fibrinolysis |
Sources: Goldman-Cecil Medicine 2 Vol Set (p. 2824-2900) | Bailey & Love's Short Practice of Surgery 28th ed. (p. 42-44) | Barash Clinical Anesthesia 9th ed. (p. 1315-1316) | Henry's Clinical Diagnosis & Laboratory Methods | Scott-Brown's Otorhinolaryngology Head & Neck Surgery (p. 293) | Miller's Anesthesia 10th ed.